32 / 62
CARDIOVASCULAR JOURNAL OF AFRICA • Volume 31, No 4, July/August 2020
194
AFRICA
term ART at a low-income urban setting in Africa. There
was a lower occurrence of historically prevalent conditions
such as tuberculous pericarditis and dilated cardiomyopathy,
while obesity, hypertension and anaemia were frequent.
Paucisymptomatic impaired LVSF and minor mitral valve
abnormalities were frequent, warranting follow up and further
research. Our results suggest the need for multidisciplinary care
with tailored cardiovascular risk stratification and screening
for cardiovascular disease, even in young HIV-positive patients
on ART, to sustain the gains in reduction of morbidity rates
and premature mortality achieved by expansion of ART in
low-income settings.
The authors thank the activists and clinical personnel of the Dream Centre
St Egidio for their contribution, particularly N Biquiza and E Bernardo,
clinical staff from INS C Funzamo, and research assistants A Ngale and M
Guiganhane. All contributed to data collection and entering during the study.
References
1.
Ball SC. Increased longevity in HIV: caring for older HIV-infected
adults.
Care Manag J
2014;
15
(2): 76–82.
2.
Dzudie A, Ojji D, Anisiuba BC, Abdou BA, Cornick R, Damasceno A,
et al
.; PASCAR Hypertension Task Force members. Development of
the roadmap and guidelines for the prevention and management of high
blood pressure in Africa: Proceedings of the PASCAR Hypertension
Task Force meeting: Nairobi, Kenya, 27 October 2014.
Cardiovasc J Afr
2015;
26
(2): 82–85.
3.
Damasceno A, Padrão P, Silva-Matos C, Prista A, Azevedo A, Lunet N.
Cardiovascular risk in Mozambique: who should be treated for hyper-
tension?
J Hypertens
2013;
31
(12): 2348–2355.
4.
López-Varela E, Augusto OJ, Gondo K, García-Basteiro AL, Fraile O,
Ira T,
et al
. Incidence of tuberculosis among young children in rural
Mozambique.
Pediatr Infect Dis J
2015;
34
(7): 686–692.
5.
Marijon E, Ou P, Celermajer DS, Ferreira B, Mocumbi AO, Jani D,
et
al
. Prevalence of rheumatic heart disease detected by echocardiographic
screening.
N Engl J Med
2007;
357
(5): 470–476.
6.
Mocumbi AO, Ferreira MB, Sidi D, Yacoub MH. A population study of
endomyocardial fibrosis in a rural area of Mozambique.
N Engl J Med
2008;
359
(1): 43–49.
7.
D’Ascenzo F, Cerrato E, Calcagno A, Grossomarra W, Ballocca F,
Omedè P,
et al.
High prevalence at computed coronary tomography of
non-calcified plaques in asymptomatic HIV patients treated with ART:
a meta-analysis.
Atherosclerosis
2015;
240
(1): 197–204.
8.
Krsak M, Kent DM, Terrin N, Holcroft C, Skinner SC, Wanke C.
Myocardial infarction, stroke, and mortality in cART-treated HIV
patients on statins.
AIDS Patient Care STDS
2015;
29
(6): 307–313.
9.
Balaji GN, Subashini TS, Chidambaram N. Detection and diagnosis of
dilated cardiomyopathy and hypertrophic cardiomyopathy using image
processing techniques.
Eng Sci Technol Int J
2016;
19
(4): 1871–1880.
10. Magula NP, Mayosi BM. Cardiac involvement in HIV-infected people
living in Africa: a review.
Cardiovasc J S Afr
2003;
14
(5): 231–237.
11. Twagirumukiza M, Nkeramihigo E, Seminega B, Gasakure E, Boccara
F, Barbaro G. Prevalence of dilated cardiomyopathy in HIV-infected
African patients not receiving ART: a multicenter, observational,
prospective, cohort study in Rwanda.
Curr HIV Res
2007;
5
(1): 129–137.
12. Sliwa K, Carrington MJ, Becker A, Thienemann F, Ntsekhe M, Stewart
S. Contribution of the human immunodeficiency virus/acquired immu-
nodeficiency syndrome epidemic to de novo presentations of heart
disease in the Heart of Soweto Study cohort.
Eur Heart J
2012;
33
(7):
866–874.
13. Chillo P, Bakari M, Lwakatare J. Echocardiographic diagnoses in
HIV-infected patients presenting with cardiac symptoms at Muhimbili
National Hospital in Dar es Salaam, Tanzania.
Cardiovasc J Afr
2012;
23
(2): 90–97.
14. Herskowitz A, Wu TC, Willoughby SB, Vlahov D, Ansari AA,
Beschorner WE,
et al
. Myocarditis and cardiotropic viral infection
associated with severe left ventricular dysfunction in late-stage infection
with human immunodeficiency virus.
J Am Coll Cardiol
1994;
24
(4):
1025–1032.
15. De Castro S, d’Amati G, Gallo P, Cartoni D, Santopadre P, Vullo V,
et
al
. Frequency of development of acute global left ventricular dysfunc-
tion in human immunodeficiency virus infection.
J Am Coll Cardiol
1994;
24
(4): 1018–1024.
16. Belperio PS, Rhew DC. Prevalence and outcomes of anemia in indi-
viduals with human immunodeficiency virus: a systematic review of the
literature.
Am J Med
2004;
116
(Suppl 7A): 27S–43S.
17. Pugliese A, Isnardi D, Saini A, Scarabelli T, Raddino R, Torre D. Impact
of highly active antiretroviral therapy in HIV-positive patients with
cardiac involvement.
J Infect
2000;
40
(3): 282–284.
18. Ushigome R, Sakata Y, Nochioka K, Miyata S, Miura M, Tadaki S,
et
al
.; CHART-2 Investigators. Improved long-term prognosis of dilated
cardiomyopathy with implementation of evidenced-based medication:
Report from the CHART studies.
Circ J
2015;
79
(6): 1332–1341.
19. Willig AL, Overton ET. Metabolic complications and glucose metabo-
lism in HIV infection: a review of the evidence.
Curr HIV/AIDS Rep
2016;
13
(5): 289–296.
20. Limsreng S, Marcy O, Ly S, Ouk V, Chanroeurn H, Thavary S,
et al
.
Dyslipidemias and elevated cardiovascular risk on lopinavir-based
antiretroviral therapy in Cambodia.
PLoS One
2016;
11
(8): e0160306.
21. UNAIDS 90-90-90: an ambitious treatment target to help end the AIDS
epidemic. Geneva: UNAIDS; 2014.
22. Palacios R, Santos J, García A, Castells E, González M, Ruiz J,
et al
.
Impact of highly active antiretroviral therapy on blood pressure in
HIV-infected patients. A prospective study in a cohort of naive patients.
HIV Med
2006;
7
(1): 10–15.
23. Thiébaut R, El-Sadr WM, Friis-Møller N, Rickenbach M, Reiss P,
Monforte AD,
et al
.; Data collection of adverse events of anti-HIV
drugs study group. Predictors of hypertension and changes of blood
pressure in HIV-infected patients.
Antivir Ther
2005;
10
(7): 811–823.
24. Jessen N, Damasceno A, Silva-Matos C, Tuzine E, Madede T, Mahoque
R,
et al
. Hypertension in Mozambique: trends between 2005 and 2015.
J
Hypertens
2018;
36
(4): 779–784.
25. Gleason B, Mirembe G, Namuyonga J, Okello E, Lwabi P, Lubega I,
et al
. Prevalence of latent rheumatic heart disease among HIV-infected
children in Kampala, Uganda.
J Acquir Immune Defic Syndr
2016;
71
(2): 196–199
26. Curkendall SM, Richardson JT, Emons MF, Fisher AE, Everhard F.
Incidence of anaemia among HIV-infected patients treated with highly
active antiretroviral therapy.
HIV Med
2007;
8
: 483–490.
27. Agarwal D, Chakravarty J, Chaube L, Rai M, Agrawal NR, Sundar S.
High incidence of zidovudine induced anaemia in HIV-infected patients
in eastern India.
Indian J Med Res
2010;
132
: 386–389.
28. Kassebaum NJ, Jasrasaria R, Naghavi M,
et al
. A systematic analysis of
global anemia burden from 1990 to 2010.
Blood
2014;
123
(5): 615–624.
29. Afana M, Brinjikji W, Kao D, Jackson E, Maddox TM, Childers D,
et al
. Characteristics and in-hospital outcomes of peripartum cardio-
myopathy diagnosed during delivery in the United States from the
Nationwide Inpatient Sample (NIS) database.
J Card Fail
2016;
22
(7):
512–519.